CAMBRIDGE, Mass., March 21, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and…
THE WOODLANDS, TX, March 21, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical…
March 20, 2025 16:30 ET | Source: Emergent BioSolutions GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc.…
Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership Allogenica received a €2.5 million…
March 14, 2025 18:15 ET | Source: Cannabix Technologies Inc. VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Cannabix…
March 07, 2025 16:05 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix,…
Company Announcement COPENHAGEN, Denmark; February 28, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant…
February 27, 2025 18:00 ET | Source: Skye Bioscience, Inc. SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience,…
SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today announced that CRN®, a brand…
February 07, 2025 16:05 ET | Source: Mersana Therapeutics, Inc. CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics,…
